VIRDIS, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 16.918
EU - Europa 5.128
AS - Asia 3.606
AF - Africa 204
SA - Sud America 74
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.945
Nazione #
US - Stati Uniti d'America 16.527
CN - Cina 1.999
IT - Italia 1.695
SE - Svezia 916
SG - Singapore 713
BG - Bulgaria 656
DE - Germania 545
TR - Turchia 412
CA - Canada 383
GB - Regno Unito 317
UA - Ucraina 259
VN - Vietnam 250
FI - Finlandia 244
RU - Federazione Russa 170
CI - Costa d'Avorio 136
CH - Svizzera 97
IN - India 90
HK - Hong Kong 86
BR - Brasile 63
FR - Francia 61
BE - Belgio 45
AT - Austria 28
SN - Senegal 25
BJ - Benin 16
NL - Olanda 16
GR - Grecia 14
ES - Italia 13
NG - Nigeria 13
JP - Giappone 12
PL - Polonia 9
IE - Irlanda 8
IL - Israele 8
AU - Australia 7
KR - Corea 6
RO - Romania 6
EU - Europa 5
HU - Ungheria 5
TH - Thailandia 5
AR - Argentina 4
CZ - Repubblica Ceca 4
HR - Croazia 4
ID - Indonesia 4
KE - Kenya 4
PK - Pakistan 4
ZA - Sudafrica 4
BN - Brunei Darussalam 3
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
IQ - Iraq 3
NZ - Nuova Zelanda 3
AM - Armenia 2
CO - Colombia 2
GH - Ghana 2
JM - Giamaica 2
LT - Lituania 2
LU - Lussemburgo 2
MY - Malesia 2
RS - Serbia 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MK - Macedonia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 25.945
Città #
Woodbridge 2.391
Houston 1.728
Fairfield 1.713
Ann Arbor 1.687
Chandler 1.093
Santa Clara 974
Ashburn 900
Seattle 734
Sofia 656
Shanghai 604
Wilmington 589
Cambridge 569
Serra 477
Beijing 461
Singapore 430
New York 408
Ottawa 364
Milan 353
Jacksonville 337
Boardman 323
Princeton 292
Izmir 274
Lawrence 272
Medford 240
Nanjing 227
Des Moines 172
Abidjan 136
Istanbul 131
Florence 110
Nanchang 106
San Diego 99
Dong Ket 98
Dearborn 89
Lancaster 88
Pisa 85
Bern 84
Boulder 82
Frankfurt am Main 79
Hong Kong 74
Falls Church 59
Kunming 58
Ogden 54
London 51
Shenyang 48
Jüchen 47
Redwood City 44
Los Angeles 42
Brussels 41
Jinan 41
Munich 40
Rome 38
Tianjin 38
Hefei 37
Changsha 36
Hebei 35
Fuzhou 33
Washington 32
Norwalk 27
Pune 27
Saint Petersburg 27
Vienna 27
Dakar 25
Hangzhou 25
Helsinki 25
Auburn Hills 23
Jiaxing 22
Nürnberg 22
Dallas 19
Hyderabad 19
Marseille 17
Cotonou 16
Phoenix 15
Orange 14
Changchun 13
Lagos 13
Bremen 12
Guangzhou 12
Lucca 12
Zhengzhou 12
Council Bluffs 11
Zurich 10
Chengdu 9
Las Vegas 9
Montignoso 8
Omaha 8
San Francisco 8
San Jose 8
Stockholm 8
Thessaloníki 8
Toronto 8
Verona 8
Lanzhou 7
Warsaw 7
Wuhan 7
Belo Horizonte 6
Detroit 6
Dublin 6
Haikou 6
Indiana 6
Lappeenranta 6
Totale 20.887
Nome #
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 229
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 203
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 190
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 187
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 177
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 175
Aging and hypertension. What about the endothelium? 173
Cigarette Smoking and Hypertension 173
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 161
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 160
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 157
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 155
Obesity in the childhood: a link to adult hypertension 152
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 150
Spironolactone improves angiotensin-induced vascular changes and oxidative stress 149
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 148
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 147
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 147
Adenosine causes angiotensin II release in human forearm arterioles. 146
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 144
Device-based therapies for resistant hypertension. 143
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 140
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. 139
Menopause is associated with endothelial dysfunction in women 138
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 136
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 134
null 134
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 134
Hypertension causes premature aging of endothelial function in humans 134
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma 133
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 133
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 133
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. 133
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 131
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy 130
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 130
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 130
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 130
Low birth weight and insulin resistance: can capillary recruitment predict hypertension development? 129
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 129
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats 128
ROLE OF NAD(P)H OXIDASE ON VASCULAR ALTERATIONS IN ANGIOTENSIN II-INFUSED MICE 128
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 128
Microvascular endothelial dysfunction in obesity and hypertension. 126
Vascular inflammation: a role in vascular disease in hypertension? 125
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 125
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension 125
Hypertension and cardiometabolic risk factors. 125
Vascular dysfunction in a mouse model of rett syndrome and effects of curcumin treatment. 125
Ventricular and vascular stiffening in aging and hypertension 124
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 123
Cutaneous vasodilation to acetylcholine in patients with essential hypertension 123
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. 123
Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertension. 122
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II 122
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 121
Age- and Sex-Specific Reference Values for Media/Lumen Ratio in Small Arteries and Relationship With Risk Factors 121
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension 121
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension 120
Blood pressure and vascular alterations with growth in childhood. 120
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients 120
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women 119
Endothelial function in hypertension 119
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 118
Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. 118
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 117
Endothelial dysfunction as a target for prevention of cardiovascular disease 116
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 116
Endothelial dysfunction and vascular disease in later life 116
Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients 115
Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients 115
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis 114
Hypertension in the elderly: an evidence-based review. 114
Forearm vasodilation to acetylcholine is increased by potassium in essential hypertensive patients 113
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction 113
Hypertension and Atrial Fibrillation: any Change with the New Anticoagulants. 113
null 112
Aging and endothelial function in normotensive subjects and essential hypertensive patients 112
Vasodilation to acetylcholine in primary and secondary forms of human hypertension. 112
Endothelial function assessment in complicated hypertension 112
Target organ damage in hypertension 112
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase. 112
Human Ghrelin: A Gastric Hormone with Cardiovascular Properties 112
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 112
Microvascular Endothelial Dysfunction in Patients with Obesity 112
Effect of potassium on vasodilation to acetylcholine in essential hypertension. 111
Endothelial function in hypertension. Evidences in humans. 110
Soluble E-selectin in essential hypertension: a correlate of vascular structural changes 110
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 110
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy 110
Human endothelial dysfunction: EDCFs 110
Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women 110
null 110
Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy 109
Age-related endothelial dysfunction is prevented by physical activity. 109
null 109
Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension 108
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 108
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. 108
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 108
Totale 12.975
Categoria #
all - tutte 78.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.078 0 0 0 0 0 0 549 381 454 285 333 76
2020/20211.881 165 110 127 101 203 89 109 191 190 184 99 313
2021/20222.927 55 181 55 176 532 401 102 185 131 144 143 822
2022/20233.159 386 330 206 280 341 442 14 266 593 37 223 41
2023/20242.342 231 228 280 142 346 468 107 58 52 47 88 295
2024/20252.964 60 348 145 446 700 926 339 0 0 0 0 0
Totale 26.430